Paediatric anaesthesia and inhalation agents

Area of Science:

• Anesthesiology
• Pediatric Medicine

Background:

• Inhalation agents are mainstays in pediatric anesthesia, particularly for mask induction before venous access is established.
• Pediatric patients often require mask induction due to needle aversion and the challenges of obtaining venous access in awake, moving children.
• Safety and precise dosing are paramount in pediatric anesthesia, facilitated by monitoring end-tidal concentrations.

Purpose of the Study:

• To review the current landscape of inhalation agents and intravenous techniques in pediatric anesthesia.
• To discuss the advantages and disadvantages of commonly used inhalation agents, such as sevoflurane and desflurane.
• To compare inhalation anesthesia with intravenous propofol in the context of pediatric patient populations.

Main Methods:

• Review of current literature on anesthetic agents used in pediatric populations.
• Comparison of safety profiles and emergence characteristics of sevoflurane, desflurane, and propofol.
• Discussion of the role of end-tidal concentration monitoring in pediatric anesthesia.

Main Results:

• Sevoflurane has largely replaced halothane, improving cardiovascular safety during pediatric anesthesia.
• Emergence from sevoflurane and desflurane can be associated with delirium and agitation.
• Experience with propofol in pediatrics is limited, and the risks of propofol infusion syndrome are not fully understood.

Conclusions:

• Inhalation anesthesia remains the gold standard for most pediatric anesthesiologists.
• Intravenous techniques, like propofol, may offer an attractive alternative in specific pediatric clinical scenarios.
• Further research is needed to fully elucidate the long-term cerebral effects and safety of certain inhalation agents and propofol in children.